Rhinomaris, 0.05% spray 15 ml
€5.14 €4.57
Pharmacotherapeutic group
Antagonist – vasoconstrictor (alpha-adrenomimetic).
ATX code: R01AA07
Pharmacokinetics
Pharmacokinetics
Almost not absorbed by local administration. Plasma concentrations are so low as to be undetectable by modern analytical methods.
Pharmacological properties
Rhinomaris is a drug for intranasal application.
Xylometazoline has alpha-adrenomimetic action: it causes nasal mucosa blood vessels narrowing thus eliminating nasopharyngeal mucosa edema and hyperemia. Facilitates nasal breathing in rhinitis. In therapeutic concentrations it does not irritate nasal mucosa, does not cause hyperemia. The action starts a few minutes after application and lasts for 12 hours.
Sterilized sea water, contained in Rhinomaris, helps maintain normal physiologic condition of nasal mucosa, thinning of mucus and normalization of its production in bocalytic cells of nasal cavity mucosa.
Micronutrients improve the function of the atrial fibrillation epithelium, reducing adverse local reactions such as irritation and/or dryness of the nasopharyngeal mucosa.
Indications
Acute respiratory diseases with rhinitis (runny nose);
allergic rhinitis (pollinosis);
sinusitis;
eustachitis;
middle otitis (to reduce nasopharyngeal mucosa edema);
preparation of patients for diagnostic manipulations in the nasal passages.
Active ingredient
Xylometazoline
Composition
Composition in mg per 1 ml of the drug: 0.05%
The active ingredient
Xylometazoline hydrochloride 0.500
Excipients
Particulate matter/p>
Adriatic Sea water 251,000
Potassium dihydrophosphate 0.502
Purified water up to 1 ml
Special Instructions
The nasal passages should be cleaned before use.
Rinomaris® should not be used for a long time, e.g. in chronic rhinitis.
Effect on the ability to drive and operate machinery
Xylomethasoline in doses exceeding the recommended ones may affect the ability to operate vehicles or equipment.
Contraindications
Arterial hypertension, tachycardia, marked atherosclerosis, glaucoma, atrophic rhinitis, thyrotoxicosis, brain surgery (in anamnesis), children under 2 years of age (for 0.05% solution), hypersensitivity to the drug components.
Precautions
Caution is used in diabetes mellitus, angina pectoris (CHD).
Side effects
In frequent and/or prolonged use – irritation and / or dry nasopharyngeal mucosa, burning, tingling, sneezing, hypersecretion, nasal mucosa edema.
palpitations, tachycardia, arrhythmias, increased BP, headache, vomiting, insomnia, visual disturbances; with prolonged use in high doses – depression.
Overdose
Symptoms: worsening of side effects.
Treatment: conducting symptomatic therapy.
.
Pregnancy use
During pregnancy and lactation the drug should be used only after careful assessment of the risk-benefit ratio for the mother and fetus, it is not allowed to exceed the recommended doses.
Similarities
Atrivin, Galazolin, Xylen, Snoop, Rinonorm, Xymelin Eco, Rinorus, Rinostop, Rinomaris, Xylometazolin, Tisin Classic, Xymelin Eco Menthol, Asterisk, Xyloct, Cold and Flu, Asterisk for Colds, Quatran xylo
Weight | 0.040 kg |
---|---|
Shelf life | 3 years. Do not use after the expiration date stated on the package. |
Conditions of storage | The drug should be kept out of reach of children at a temperature not exceeding 25°C. |
Manufacturer | JADRAN-GALENSKI LABORATORY a.s., Croatia |
Medication form | nasal spray |
Brand | JADRAN-GALENSKI LABORATORY a.s. |
Related products
Buy Rhinomaris, 0.05% spray 15 ml with delivery to USA, UK, Europe and over 120 other countries.